MedTrace Logo

Low Intensity Shock Wave Therapy in the Management of Erectile Dysfunction

NCT04136288 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2024-11-12

Study results available
· View outcomes & findings →

Summary

Researchers are evaluating the efficacy of low intensity shockwave therapy (LISWT) via MoreNova in the treatment of erectile dysfunction (ED).

Conditions

Interventions

DEVICE

MoreNova

Shockwave therapy delivered to the genital area with low dose shocks

Sponsors & Collaborators

Principal Investigators

  • Gregory Broderick, MD · Mayo Clinic

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-01
Primary Completion
2023-07-01
Completion
2023-07-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04136288 on ClinicalTrials.gov